ALDR1EUR
Alder Biopharmaceuticals Inc
Clinical-stage biopharmaceutical company focused on migraine treatment development, acquired by H. Lundbeck A/S in October 2019
CUSIP: 014339105HealthcareUS1 holder
Recent Activity
2018Q2
1 sell
-189.5K shares
Leon CoopermanEXIT
-189.5K shares
Loading more activity...